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Aging is one of the greatest risk factors for the development of sporadic age-related
neurodegenerative diseases and neuroinflammation is a common feature of this
disease phenotype. In the immunoprivileged brain, neuroglial cells, which mediate
neuroinflammatory responses, are influenced by the physiological factors in the
microenvironment of the central nervous system (CNS). These physiological factors
include but are not limited to cell-to-cell communication involving cell adhesion
molecules, neuronal electrical activity and neurotransmitter and neuromodulator
action. However, despite this dynamic control of neuroglial activity, in the healthy
aged brain there is an alteration in the underlying neuroinflammatory response
notably seen in the hippocampus, typified by astrocyte/microglia activation and
increased pro-inflammatory cytokine production and signaling. These changes
may occur without any overt concurrent pathology, however, they typically
correlate with deteriorations in hippocamapal or cognitive function. In this review
we examine two important phenomenons, firstly the relationship between age-
related brain deterioration (focusing on hippocampal function) and underlying
neuroglial response(s), and secondly how the latter affects molecular and cellular
processes within the hippocampus that makes it vulnerable to age-related cognitive
decline.
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Introduction
Aging
Aging is a natural biological process that is universal and intrinsic to all animals. It is progressive,
time-dependent, and deleterious in nature and results ultimately in physiological decline, but
exhibits variability between individuals (Lister and Barnes, 2009). With respect to the brain,
in humans and rodents, one of the most common occurrences indicative of the normal aging
process, is an association with cognitive decline, even in many cases without a major pathological
component. Due to advances in healthcare, there has been an increase in the life expectancy of
humans, with the fastest increasing age group being amongst those who are 85 years and over.
According to the office of national statistics (USA), by 2034 it is projected that 5 per cent of the
total population will be over 85 years. Since aging is a major risk factor, albeit not a cause, there
is a greater propensity to develop dementia as we age (Bishop et al., 2010). Thus understanding
the major underlying mechanisms that accompany the normal process of aging will be important to
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dissect the processes that amplify the vulnerability of the brain to
the development of age-related cognitive decline.
Normal Aging and Pathological Aging
Defining the boundaries of normal physiological change as
distinct from pathological conditions poses a major challenge
in the study of the brain aging process. For example, in
Alzheimer’s disease, an age-related neurodegenerative condition
characterized by progressive decline in cognitive function,
there are widespread depositions of amyloid plaques and
neurofibrillary tau pathology accompanied by aberrant
neuroinflammatory responses in the brain. These changes
have also been consistently reported in some population
of healthy non-agerians or centenerians (Braak and Braak,
1991). The dramatic increase in the probability of aged
individuals (>85 years) suffering from late onset-sporadic
neurodegenerative diseases like AD is an evidence of the
impact of aging. (Mattson and Magnus, 2006). This raises the
question as to whether aging might represent (i) a very early
indicator of a pathological process, whereby aging is prodromal
to age-related neurodegenerative diseases and occurs along a
continuum, albeit at different rates in individuals. Or (ii) whether
clear distinct differences in some histopathological findings
between normal and pathological aging are purely associated
with an independent activated pathway involving genetic
predisposition, separate molecular and cellular mechanisms,
as well as susceptibility to environmental factors (Dickson
et al., 1992; Mattson and Magnus, 2006). In this review we will
explore the role of one common mechanism seen in normal
and pathological aging (i.e. neuroglial/neuroinflammatory
responses) and its impact on specific aspects of brain
function.
Evidence of Deficit in Hippocampal
Function in Aging
The normal aging process is associated with conserved pathways
that are affected early, before more widespread decline (Braak
and Braak, 1991). One such region, that is very vulnerable and
susceptible to hallmark features of age-related neurobiological
alterations is the hippocampus. The hippocampus is embedded
deep within the medial temporal lobe of the brain and is
particularly important because of its key role in the formation
of episodic-declarative memory and cognitive function.
A number of studies in humans have correlated memory
impairment in apparently healthy elderly individuals with
features of medial temporal lobe amnesia (Craik and Jennings,
1992; Golomb et al., 1993; Petersen et al., 2009). For example,
Golomb et al. (1993) found that elderly individuals with
hippocampal atrophy performed poorly on tests for declarative
memory. Also neuroimaging and cognitive neurophysiological
studies that measure cerebral blood flow during encoding
and recognition of faces have reported deficits in memory
performance in healthy elderly subjects associated with
hypoactivity in the hippocampus (Grady et al., 1995). This
age-related memory deficits can be primarily attributed to a
functional impairment in medial temporal lobe encoding of
new information, which serves as a basis for recall/recognition,
rather than a deficient medial temporal lobe function during the
retrieval of information (Gallagher and Rapp, 1997). In support
of this hypothesis, Schacter et al. (1996) reported that during
a word-stem completion task by elderly subjects, hippocampal
activation in both young and aged groups were similar during
successful recall of studied words. However, it is noteworthy to
mention that this age-related impairment is not evident in all
elderly individuals, probably due to different levels of resilience
and cognitive reserve. Another common finding in age-related
cognitive neuropsychological studies was that during memory
retrieval or recognition, older individuals also showed bilateral
prefrontal cortex activity while younger matched pairs showed
right prefrontal cortical activity (Aine et al., 2011). These cortical
regions have been associated with a role in executive functioning
and other higher cognitive functions. The changes in cortical
activity have been attributed to a process of compensation
or recruitment of other brain regions to help maintain
good performance following age-related hypoactivity in the
hippocampus, and may also signal a surrender of other cortex-
dependent higher cognitive functions, such as executive function
of attention, abstract thinking, and daily task planning. In aged
non-human primates there is also considerable body of evidence
to associate hippocampal deterioration with cognitive decline.
For example, the activation of the hippocampus is reduced
when aged adults perform memory related tasks dependent on
the medial temporal lobe (Small et al., 2004). Reduced blood
flow in the hippocampus was demonstrated also in aged rhesus
monkeys, accompanied by a decrease in expression of activity
regulated cytoskeletal (Arc) protein, an indicator of neuronal
activity (Small et al., 2004). The development of behavioral tests
geared towards the evaluation of cognitive changes across the
lifespan in rodents has aided testing for impaired cognition in
aging. One widely used rodent model dependent on the integrity
of the hippocampus, the Morris Water Maze (Morris et al.,
1986) capitalizes on the observation that experimental tasks
measuring visuospatial learning (a reference associated property
of declarative memory) are also sensitive to aging in rodents
(Rapp et al., 1987). In this hippocampal-dependent task, rats
are trained to find a hidden platform below the surface of the
tank based on external cues. Numerous studies have reported
that young rats can learn to swim directly to the escape platform
after relatively few training trial runs (Rapp et al., 1987; Zyzak
et al., 1995; Rapp and Gallagher, 1996). Aged rats (>20 months
of age) on the other hand exhibit neurobehavioral deficits in
this pre-learned task that are qualitatively similar to the effects
of hippocampal damage, and occur independent of decline in
sensorimotor/motivational functions (Rapp et al., 1987; Zyzak
et al., 1995; Rapp and Gallagher, 1996).
Glial Cell Responses in the Brain
Inflammation in the brain is defined by upregulated astrocyte
and microglial cell reactivity coupled with increased levels
of circulating cytokines such as TNFα, IL-1β, IFN-g (Lynch,
1998a,b; Lynch and Lynch, 2002; Streit et al., 2004). Although
the brain has long been described as an immunologically
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privileged organ, in comparison to the peripheral system its
immunological properties per se are not as robust. For example
it lacks a lymphatic system to capture a potential antigen
threat, its expression of major histocompatibility complexes
(MHC I and II) is exceptionally low and the specialization
of the blood brain barrier (BBB) also makes it difficult for
infiltrating cells to permeate the brain parenchyma under normal
conditions (Lynch, 2010). Nonetheless it is clear from studies of
aging and age-related neurodegenerative disease that one of the
major common hallmarks is an underlying neuroinflammatory
response. Knowledge of these responses are therefore needed
in order to further understand the cause and subsequent
effect of these potentially damaging inflammatory changes that
could be a pivotal driving force in the process of brain aging
and related diseases. In this review we discuss the current
major topics as they relate to age-related neuroinflammation
in the ‘‘hippocampus’’ with a major focus on microglia
responses.
Astrocytes and Microglia
In the brain protoplasmic, fibrous and radial glia astrocytes
located in the gray and white matter and axis of the ventricles
respectively, by far outnumber neurons and are amongst the
most numerous populations of glial cells in the brain. They
perform a wide range of adaptive functions in normal brain
physiology, such as: maintenance of BBB, regulation of ion
homeostasis, synthesis and secretion of trophic/inflammatory
factors, cell/tissue repair and regeneration, neurotransmitter
uptake, lipid synthesis, synaptic transmission and regulation
of synaptic density. In response to acute injury, astrocytes
undergo cellular alterations including swelling, hypertrophy
(astrogliosis) and proliferation (astrocytosis), characterized by
increased expression of cytoskeletal protein GFAP, metallic
impregnation and ultrastructural examination.
Microglia cells account for 10% of total glial cell population
in the brain. They are referred to as resident macrophages
and representative of the brains innate immune system. Their
expression of MHC antigens, T- and B-Lymphocyte markers
and other immune cell antigens, in the relatively immune
privileged central nervous system (CNS) couples microglia to
the adaptive immunity mediated by lymphocytes. Microglia are
the first barrier of defense in the CNS, and have a ubiquitous
distribution in the brain parenchyma, continuously surveying
their microenvironment through their highly motile processes
(Rezaie, 2007). Microglia predominate in gray matter, with
high concentrations in the hippocampus and substantia nigra
(McGeer et al., 1988; Lawson et al., 1990), and with a somewhat
heterogeneous population in different regions of the brain
(Carson et al., 2007).
There are two major distinct populations of microglia cells
in the brain. (i) Short-lived, frequently replaced microglial cells
derived from circulating monocytes /macrophage sources, that
are concentrated in perivascular and some parenchyma regions
(Kennedy and Abkowitz, 1997; Vallières and Sawchenko, 2003),
and (ii) long-lived resident microglia cells which are abundant
in all CNS parenchyma (Kennedy and Abkowitz, 1997; Vallières
and Sawchenko, 2003).
Quiescent microglia cells, when not challenged are
characterized by a small cell body, ramified process/morphology
with weak expression of associated cell surface marker antigens.
Upon activation in response to stimuli, activated microglia are
considered to be initially neuroprotective/reparative in nature in
their activity, playing vital roles in supporting and maintaining
neuronal function, homeostasis and survival in normal and
pathological microenvironment (von Bernhardi et al., 2010).
Upon activation they undergo an initial dramatic morphological
change that includes enlargement of the cell body and shortening
of cellular processes. This is swiftly followed by proliferation
and migration to the lesion site along a chemokine gradient.
Proliferating microglia cells shield injury sites, phagocytose
potentially deleterious tissue debris or dying cells, release
cytokines and secrete neurotrophic factors to promote tissue
repair and support growth of damaged neurons.
However, when microglia are dysregulated, their
overactivation can be detrimental and result in a continuum of
changes (Block and Hong, 2005; Town et al., 2005). Uncontrolled
microglia responses may be harmful to survival of injured
neurons if their activation supersedes threshold of tolerability,
resulting in damage rather than a defensive sentinel role afflicted
by excessive neuroinflammation (O’Keefe et al., 2002; Rezaie,
2007; Varin and Gordon, 2009). This sequelae of events briefly
involves uncontrolled phagocytosis, induction of T-cell response,
secretion of pro-inflammatory neurotoxic molecules and short-
lived potentially cytotoxic species, such as nitric oxide (NO) and
reactive oxygen species (ROS) which inevitably contribute to
oxidative stress and mitochondrial dysfunction.
These microglia phenotypes have been speculated to be
somewhat similar or analogous to the innate immune response
of macrophages in the periphery, characterized by their
adaptation of different activation states, involving upregulation
of specific markers, in response to different signals (Gordon,
2003; Mosser, 2003; Saijo and Glass, 2011; Varnum and
Ikezu, 2012). This classification is broadly described as
the M1 pro-inflammatory phenotype or classical activation
state, induced by Th1 cell derived cytokine IFN-γ, and
identified by upregulation of TNFα, IL-1β, iNOS, and the
distinct M2 anti-inflammatory/neuroprotective pathway or
alternate activation state. The latter induced by the Th2 cell
derived cytokines, IL4, IL5, IL10, IL13 and identified by the
upregulation of mRNA expression of arginase I, mannose
receptor, chitinase 3-like 3 (YM1) and found in inflammatory
zone-1. M2 phenotype is characterized by the inability to
produce NO and other cytotoxic/proinflammtory compounds,
inefficiency at antigen presentation and stimulation of T cell
proliferation.
Astrocyte and Microglia Responses in the Aged
Brain: Changes in Morphology, Density,
Phenotype, Proteomic and Gene Profiles
GFAP protein and mRNA levels of resident populations of
astrocytes are known to become elevated in aged rodent brains,
notably in the hippocampus (Goss et al., 1991; Nichols et al.,
1993; Kohama et al., 1995; Ojo et al., 2011). Histological studies
Frontiers in Aging Neuroscience | www.frontiersin.org 3 April 2015 | Volume 7 | Article 57
Ojo et al. Aging, neuroglial cells and hippocampal deterioration
have noted age-related changes in morphological characteristics
of astrocytes in the hippocampus (see Figures 1D–G). These
cells were described as being ‘‘fibrous’’ in nature, albeit without
appreciable numerical changes with age (Geinisman et al., 1978;
Hughes and Lantos, 1987; Mandybur et al., 1989; Bronson
et al., 1993; David et al., 1997; Long et al., 1998). Thus it
appears that with age the primary astrocytic change appears
to be hypertrophy, rather than hyperplasia i.e., increase in cell
numbers, and this is consistent in both humans and rodents.
However, it is also worth mentioning that some few studies
have also reported decreases in astroglial density with age
(Nishimura et al., 1995; Cotrina and Nedergaard, 2002; Wu
et al., 2005). Such discrepancies could be attributed to the use
of GFAP as a universal marker of astrocytes. GFAP does not
adequately delineate the very complex structure of individual
astrocytes, which has extremely elaborate cellular processes
(Rodríguez et al., 2014). This is further complicated by the
heterogeneity in subpopulations of GFAP positive astrocytes
between different regions of the brain (Kimelberg, 2004).
Microarray analysis of the astrocyte transcriptome in the aging
brain following isolation by laser capture microdissection
has also shown dysregulation of genes associated with actin
FIGURE 1 | Morphological changes to astroglial and microglial cells in
the aged hippocampus. Robust activation of microglial cells typified by an
increase in cell density and expression of cell surface markers, such as, major
histocompatibility complex class II (MHCII) is evident in the aged hippocampus
of rodents (A,B). This is notable in the CA3 and dentate gyrus regions of the
hippocampus involved in learning and memory (A). These microglial cells show
intense electron dense staining for phagolysosomes following electron
microscopic examination (C). Astroglial cells in aged hippocampus become
hypertrophic and increase their expression of glial fibrillary acid protein (GFAP), a
marker of astrogliosis (D,E). These cells demonstrate an enlarged cell body and
reduced cellular processes (F,G). Scale bar in (D) represents 733 µm in (A,D);
65 µm in (B,E); and 7.25 µm in (F,G). Scale bar in (C) represents 1.25 µm.
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cytoskeleton, proliferation, apoptosis, and ubiquitin-mediated
proteolysis, including altered regulation of intracellular
signaling pathways, such as, insulin growth factor signaling,
phosphatidylinositol 3-kinase (PI3K)/Akt, and mitogen-
activated protein kinase (MAPK) pathways (Simpson et al.,
2011).
In contrast with the astrocyte response, significantly more
studies have been conducted to investigate the role of microglia
cell response to brain aging. Increased expression of MHCII
activated/primed microglia marker, and upregulated phagocytic
activity has been shown by electron dense inclusions in microglia
of advanced aged animals (Peters et al., 1991; Ogura et al., 1994;
Sheffield and Berman, 1998; Ojo et al., 2011; see Figures 1A–C).
Several ex vivo studies of the aged rat and human hippocampus
have demonstrated morphological changes in microglial cells
from a ramified to an activated state with thicker processes
and larger cell somata. This is accompanied by an increase
in the expression pattern of pro/inflammatory and antigen
presenting markers like CD11b, MHC-II, IL-1β (and its receptor
IL-1RI), IL-6, IL-18, TNFα and a decrease in the levels of anti-
inflammatory cytokine markers IL-4, IL-10 and TGFβ (Lawson
et al., 1990; Htain et al., 1994; Ogura et al., 1994; Streit,
2002; Godbout et al., 2005; Maher et al., 2005; Nolan et al.,
2005; Griffin et al., 2006; Lyons et al., 2009). Jimenez et al.
classified this age-dependent response as a switch from the
alternative M2 to the classical M1 phenotype (Jimenez et al.,
2008). Moreover, with age, activated/primed MHCII+ microglia
cell density increases dramatically within the hippocampus in
rodents (Perry et al., 1993; Ogura et al., 1994; Ojo et al.,
2011), and microglia cells derived from 24-month old rodent
brains also demonstrate greater proliferative capacity than cells
derived from 12 month-old or younger animals (Rozovsky et al.,
1998).
Reports in vitro have also demonstrated that microglia
cells obtained by cell sorting from 18 month-old rodents
present with lipofuscin granules, an insoluble, autofluorescent
glycolipoprotein and by-product of lipid peroxidation, a
reduction in cellular process complexity, altered granularity,
increased mRNA levels of pro-inflammatory (TNF α, IL-1β,
IL-6) and reduced levels of anti-inflammatory cytokines (IL-10,
TGFβ1) compared to 2 month-old rodents (Ye and Johnson,
2001; Maher et al., 2005; Nolan et al., 2005).
The extent of microglia gene expression profiles and brain
specific transcription patterns have also been examined in
a systematic and comprehensive manner using the well-
powered microarray technology. These studies have been able to
monitor functional classes of genes showing altered expression
in cognitively normal aging across the adult lifespan (age
20–99 years), and have reported that ‘‘immune activation is a
highly prominent feature of cognitively normal brain aging which
additionally primes the brain for neurodegenerative cascades and
cognitive decline’’ (Lukiw, 2004; Cunningham et al., 2005; Perry
et al., 2007; Berchtold et al., 2008; Holmes et al., 2009; Burger,
2010; Cribbs et al., 2012).
Cribbs et al. (2012) recently reported the response
profiles of these genes implicated with brain aging, and
these included a continuum of widespread upregulation in
pro-inflammatory genes such as complement components, Toll
like receptor signaling (TLRs), inflammasomes, scavenger and
immunoglobulin (Fc) receptors and human leukocyte antigens
I and II, reflecting activation of microglia and perivascular
macrophages. Others have also reported upregulation in
DAXX, a Fas binding protein, apoptosis mediator, cytosolic
phospholipase A2, Nuclear factor κB (NF-κB), apoptosis
signaling cell surface antigen TNFR family death receptor,
Fas, IL-1β, IL-1α and cyclo-oxygenase-2 (COX-2) signaling
in the hippocampus (see Colangelo et al., 2002; Lukiw, 2004).
These changes were also coupled with a downregulation of select
factors, such as: TOLLIP, fractalkine, IL-4, and CD200, C3CX3L1
which are known to be inhibitory to microglial/macrophage
activation (Lukiw, 2004; Cribbs et al., 2012). Notably in all these
gene expression profiling studies, essentially all pathways of
the innate immune system were upregulated in aging, and this
was associated with brain regions vulnerable to accumulating
pathology in brain aging, namely the hippocampus, entorhinal
cortex and superior frontal gyrus, all critical for higher cognitive
function.
Such glial specific cell changes, however, do not occur
in isolation, but likely in the context of increased cellular
stress responses or deficiencies in cellular ‘‘coping mechanisms’’
that are associated with aging (Amenta et al., 1998; von
Bernhardi et al., 2010). Collectively, glial cell activation in
parallel with such physiological changes could be considered
as the driving factors, although not exclusively (see Conde
and Streit, 2006), contributing towards the cognitive decline
seen in old age (Schipper, 1996; Simpson et al., 2010; von
Bernhardi et al., 2010; Rodríguez and Verkhratsky, 2011), and
therefore could be a potential target for preventive treatment, or
‘‘prophylactic’’ therapy.
Microglia Senescence in Aging
Reports of extensively distributed senescent age-related
dystrophic microglial cells have been shown throughout the
brain in human subjects (Streit et al., 2004; Reichenbach et al.,
2010). The morphological feature of dystrophic microglia
as described by Striet et al., include: deramification or
decreased arborisation of their processes, loss of finely branched
cytoplasmic process, cytoplasmic beading/spheroid formation,
shortened and twisted cytoplasmic processes and instances of
partial or complete cytoplasmic fragmentation (Streit et al., 2004;
Reichenbach et al., 2010).
Although the mechanisms involved in this characteristic
age-related morphological transformations are unknown, it is
believed that oxidative products that accumulate in microglia
during aging (Hayashi et al., 2008; Lopes et al., 2008)
make them vulnerable to oxidative damage and cell death.
Microglial senescence might also result from a process
involving telomere shortening, similar to immunosenescence
of macrophages. Telomeres, which are the physical end of
eukaryotic chromosomes continually shorten with age and
divide due to the instability of DNA polymerase to completely
replicate DNA molecules. Therefore when cells exhaust their
replicated potential they enter replicative senescence, resulting
in substantial damage to cell function and gene expression.
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Telomere shortening in rat microglia has been demonstrated
over time in vitro/in vivo (Flanary and Streit, 2003). As microglial
cells have a considerable capacity for cell division in the
CNS (Clarke et al., 2008), a reduction in telomere length
shortening could potentially damage their ability to combat
pathological occurrence in the brain (Flanary et al., 2007).
Senescence could cause microglia to function abnormally with an
aberrant proliferative capacity, impaired clearance mechanism
and reduced production of anti-inflammatory products. An
increase in these distinct populations of dystrophic senescent
microglial cells with age could therefore cause microglial cells
to inevitably lose their vital homeostatic functional role in the
CNS. This failure to respond adequately to external stimuli could
thus eventually contribute towards neurodegeneration seen with
aging (Streit, 2006; Streit et al., 2009).
Glial Activation, Oxidative Stress and AGEs
Activated glial cells in the aged brain have been shown to
increase their generation of by-products of oxidative metabolism
including ROS—hydrogen peroxide, hydroxide ions, NO and
peroxynitrite (Lynch, 1998b, 2010; Streit et al., 2004). These
cytotoxic molecules can diffuse to other parts of the cell,
damaging proteins, nucleic acids and lipids, causing oxidative
stress, dysfunction of mitochondria and their membrane
integrity, and subsequent activation of apoptotic mechanisms.
One important by-product of glial oxidative metabolism is the
production of advanced glycation end-products (AGEs), which
are proteins that form non-enzymatically in a reaction between
reducing sugars, amino groups of proteins and other compounds.
AGEs are known to increase in aging in humans and rodents
(Kimura et al., 1996, 1998) and engagement with the AGE
receptor (RAGE) expressed prominently on microglial cells can
activate the common NF-kappaB signaling pathways that is
involved in stimulating oxidative stress, apoptosis and pro-
inflammatory responses (Kimura et al., 1996, 1998).
In addition to the increase in by-products of oxidative
metabolism, glial cells particularly astrocytes produce
antioxidant glutathione and supply their precursors to
neurons. This pivotal oxidative stress defense enzyme is
known to greatly decrease with aging in the brain and plasma,
resulting in the susceptibility to oxidative stress (Butterfield and
Sultana, 2007). Such age-related peculiarities in anti-oxidant
protection can be partly attributed to the switch in the metabolic
support of astroglia to inflammatory cells capable of inducing
neuroinflammation through production of pro-inflammatory
and cytotoxic factors (Fuller et al., 2009).
Microglia Priming in Aging
In the aged hippocampus of rodents, microglia activated by
single acute exposure to small concentrations of systemic LPS
(Henry et al., 2009; Frank et al., 2010) have been shown to
exhibit an increase in mRNA and protein expression of pro-
inflammatory genes (IL-1β and IL-6, CD11b, MHCII, Toll-
like receptor, indoleamine 2,3 dioxygenase) and reduced anti-
inflammatory cytokine levels compared to age-matched controls.
Although humans and animals are rarely exposed to a
single acute systemic inflammatory event, such as, sepsis, they
can however, encounter low concentrations of inflammatory
toxins over a prolonged period. Perry and Colleagues recently
demonstrated a similar effect on glial cell responses in the
brains of rodents exposed to long-term systemic inflammation
(Püntener et al., 2012). In a set of elaborate experiments by
Püntener et al. (2012) it was demonstrated that injections
with bacterial infectious agent Salmonella typhimurium was
able to cause acute, transient behavioral changes and a robust
peripheral immune response, peaking at day 7 after treatment.
This resulted in a delayed and prolonged cytokine (IL-1β,
IL-12, TNF-α) synthesis, followed by an activated microglia
and cerebrovascular phenotype persisting until 4 weeks post
infection in the brain of aged animals compared to age-
matched controls. In addition, subsequent focal inflammatory
challenges with LPS in these animals were able to prime
brain innate immune responses, causing hyper-induction of
pro-inflammatory molecules. These studies provide convincing
evidence that suggests the inflammatory status of aged microglia
is (hypo)tolerant and (hyper)primed to become inevitably over
responsive to low-grade stimuli, such as, acute stress-related
systemic inflammation experienced throughout life.
Age-related Neuroinflammation and
Impact on Hippocampal Neurogenesis
In the adult mammalian brain, located within the subgranular
zone (SGZ) of the dentate gyrus are neuronal progenitor cells,
which generate thousands of new neurons on a daily basis
(Altman and Das, 1965; Cameron et al., 1993; Kuhn et al.,
1996). These newly generated post-mitotic neurons, extend
their axons rapidly and migrate to the granule cell layer
after cell division, where they mature to develop a neuronal
phenotype and morphology. Some emerging evidence suggests
that neurogenesis plays a pivotal role in hippocampal function,
particularly in memory consolidation and spatial learning
(Shors et al., 2001). Impairment in hippocampal neurogenesis
may therefore be linked to cognitive decline. A number of
studies have shown that neurogenesis in the hippocampus
dramatically declines with age (Seki and Arai, 1995; Kuhn
et al., 1996; Rao et al., 2005; Olariu et al., 2007). This
reduced potential of the aged brain to generate a constant rate
of neuronal cell turnover has been attributed to age-related
neuroinflammation. This role was elegantly demonstrated in an
in vivo study showing that LPS induced inflammation gives rise
to microglia activation in the close proximity of newly formed
neurons in the SGZ, and strongly impaired basal and insult
triggered neurogenesis reflected by a reduction in BrdU/NeuN+
immature neurons in rats (Ekdahl et al., 2003). Moreover
the impaired neurogenesis associated with inflammation was
restored by systemic administration of minocycline, which
inhibits microglia activation, suggesting that impairment in
neurogenesis depends on the degree of microglia activation. The
mechanism(s) by which age-related localized neuroinflammation
in the hippocampus compromises the survival of newly born
hippocamapal neurons is currently unknown. However, the
role of releasable cytokines, such as IL-1β, IL-6, NO, TNFα
from localized microglia and astrocytes (Ekdahl et al., 2003;
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Hanisch and Kettenmann, 2007) and diminished production
of growth factors such as brain-derived growth factor (BDNF)
and fibroblast-derived growth factors (FGF) primarily produced
by hippocampal astrocytes in the dentate gyrus has been
proposed to impact on local and systemic external factors
in the neurogenic zone (niche). Consequently, impairing the
activation of quiescent stem cells, the mitotic potential of
proliferating precursors, and the survival of neuronal fate-
committed precursors.
Age-related Neuroinflammation and
Impact on Vascular Dysfunction and
Associated Comorbidities
A dynamic network of microvessels function to meet the brain
metabolic demands. This vital neurovascular unit comprises
of endothelia cells, astrocytic end-feet processes, pericytes,
smooth muscle cells, neurons and neighboring perivascular
microglia processes. Impairments in cerebrovascular function
therefore carries with it detrimental consequences. It is
increasingly evident that there are subtle structural changes to
cerebral microvascular integrity in the brains of non-demented
elderly individuals without overt concurrent neuropathology.
Some of these significant age-related impairments in the
vascular network of small vessels, such as, arterioles and
capillaries of the basal forebrain regions and the hippocampus
are characterized by; (i) reduced vessel density; (ii) venous
collagenosis; (iii) tortuosity lesions; (iv) thickened arteriolar and
capillary walls/arteriosclerosis; and (v) deposition of lipofusin,
dystrophic, calcified glial elements or corpus amylacea and in
some cases cerebral amyloid angiopathy (CAA) around blood
vessels (Braak, 1979; Scheibel, 1984; Mrak et al., 1997; Esiri
et al., 1999; Breteler, 2000; Esiri, 2000; Weller et al., 2002;
Love et al., 2003; Vasilevko et al., 2010). These data together
indicate that vascular deterioration in the aged brain appears
to have strong implications for neurodegeneration, and affect
longitudinal cognitive trajectories adversely, perhaps leading to
cognitive decline in aging (Richardson et al., 2012; Vemuri
et al., 2015). The consequences of such deficits in vascular
integrity couldmanifest itself by causing the loss of vascular auto-
regulation associated with rigidity of arterioles and insufficient
perfusion of branching vessels in the territory of susceptible
areas such as the temporal cortex and hippocampus (Popa-
Wagner et al., 2014). Functional neuroimaging studies that detect
cerebral blood flow and integrity have provided conspicuous
evidence that corroborates a slow but progressive systematic
breakdown of cerebral vascular perfusion with aging (Martin
et al., 1991).
Such deficits in vascular perfusion among the elderly have
been linked with other age-related comorbidities such as vascular
dementia associated with CAA and late-life vascular depression
(Brevik et al., 2013; Muresanu et al., 2014). Intriguingly the latter
has been shown to greatly increase the risk of cognitive decline in
aged individuals (Lenze et al., 2005), including other age-related
diseases affecting the cardiovascular, cerebrovascular, neuro-
endocrine and immune systems (Popa-Wagner et al., 2014).
Depression has long been associated with increased markers of
inflammation (such as: IL-6, IL-8, IFN-γ, TNF-α, CRP) in the
periphery (Popa-Wagner et al., 2014). In such circumstances it
is possible that on the background of systemic inflammation
with aging, where there is already a chronic low-grade pro-
inflammatory state in the brain, pro-inflammatory cytokines in
the peripherymay additionally gain access to the CNS and trigger
microglial activation and subsequent neuroinflammation (Dilger
and Johnson, 2008; Ransohoff and Cardona, 2010; Popa-Wagner
et al., 2014). This in turn could consequently result in a self-
perpetuating event involving further activation of inflammatory
responses in the brain and precipitation of depressive-like
symptoms and cognitive decline.
Additionally, age-related comorbid vascular changes are
commonly reflected in regional and laminar patterns that
parallel patterns of perivascular or localized parenchymal
inflammation (Buée et al., 1994; Richardson et al., 2012).
Consistent with this histopathological outcome, mouse models
subjected to chronic cerebral hypoperfusion also intriguingly
display marked increase in vascular/perivascular infiltration
of inflammatory cells (Reimer et al., 2011; Okamoto et al.,
2012). As a result, underlying age-related neuroinflammatory
processes (in the brain and also periphery) have been considered
to be a potent contributor (and/or a predisposing factor)
for age-related microvascular damage. With the vascular
brain endothelium and associated cells thought be the point
of convergence for mechanisms of inflammatory-associated
damage. This may occur through the accumulative effect of
low grade inflammatory factors, such as: nitric oxide (NO),
thrombin, tumor necrosis factor-α (TNFα), transforming growth
factor-b (TGF-β), interleukin (IL) IL-1β, IL-6, IL-8 (NFκ-
B signaling), VCAM, ICAM and matrix metalloproteinases
(MMPs) released from activated glial and perivascular cells,
and impacting on microvascular function. We postulate that
the outcome of these responses in the brain could lead
to: (i) alterations in cerebral blood flow/perfusion through
inflammatory vasodilators; (ii) activation of death signaling
pathways in endothelial cells, smooth muscle cells, and pericytes;
(iii) providing signals for perivascular cell invasion into the
brain; (iv) disruption of BBB integrity; and (v) alterations
in perivascular drainage/clearance (or CSF turnover) through
abluminal transport mechanisms. These mechanisms in aging
have not been greatly explored and should be considered in
future preclinical studies.
Role(s) for Neuroglial Cells in Synaptic
Function and Age-Related Spatial Learning
Deficits
Another aspect of neuron-glia interaction often overlooked and
which is of vital importance to normal physiology is the support
of synaptic function, in which astroglia and microglia are of
particular importance.
The elaborate dynamic processes of resting microglial
cells have been shown by in vivo live imaging studies to
contact synapses vigilantly monitoring and responding to
biochemical perturbations (Wake et al., 2009). For example
resting microglia processes under physiological conditions
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reportedly made brief but frequent direct contacts at synapses
lasting 5 min, however in conditions whereby neuronal activity
was upregulated the frequency of contacts was reduced, with
direct contacts lasting for 1 h. In pathological cases the spatio-
temporal interaction between microglia and synapses was even
more markedly prolonged and occasionally followed by the
disappearance of synaptic structures i.e., boutons and spines
(Trapp et al., 2007; Wake et al., 2009; Tremblay et al., 2010).
This unique role of microglia clearance has been suggested
to involve components of the MHC class I molecule and
proteins from the complement cascade, for example C1q and
C3-CR3/CD11b-CD18/Mac-1 complement-phagocytic receptor
complex localized to synaptically enriched regions, which have
been documented to selectively tag synapses in the developing
visual system at a time when refinement and synaptic remodeling
and plasticity of neuronal circuits occur. A number of studies
have reported that during aging there is a loss of synaptic contacts
in the CNS especially in the hippocampus (Geinisman et al.,
1986a,b; Nicholson et al., 2004) accompanied by an underlying
microglial activation displaying increase phagolysosomal vesicles
and an increase in microglia-synaptic interactions (Ojo et al.,
2012, 2013). Primed/activated microglia cells may therefore have
a major role in the elimination and disruption of these synaptic
connections with aging (Ojo et al., 2012, 2013) and studies to
examine the cellular and molecular cascades involved would be
important in order to understand the contribution of microglial
cells to the plasticity of neuronal circuits in the aging brain.
Several neurochemical parameters in the hippocampus
implicated in synaptic plasticity, including learning and memory
processes, are sensitive to immuno-active molecules produced
primarily by microglia and to a lesser degree by astrocytes.
Cognitive function is disrupted by neuroinflammation following
IL-1β, IL-18, and LPS treatment in rodent models. For example,
treatment with pro-inflammatory cytokine IL-1β, which
increases notably with aging or products that increase its
levels indirectly, inversely correlates with the ability of rats
to sustain long-term potentiation LTP, a classical paradigm
of spatial memory (see Lynch, 1998a). IL-1β disrupts LTP
via activation of IL-1 type I receptor signaling (IL-1R1)
(expressed at a high density in the hippocampus) and through
the phosphorylation of stress-activated protein kinase, c-jun
N-terminal kinase (JNK) death associated cellular pathway
(Barry et al., 2005; Moore et al., 2007). IL-1β can also
stimulate lipid peroxidation through production of free
radicals, consequently decreasing membrane polyunsaturated
fatty acids, such as arachidonic acid, a well known putative
retrograde messenger involved in synaptic plasticity and
the expression of LTP (Bliss and Collingridge, 1993). This
peroxidative process subsequently alters membrane fluidity
and induces biophysical changes on membrane associated
functions, such as: impaired ion channels-pumps and enzymatic
activity of lipases/kinases, reduced receptor density and
associated functions (Lynch, 1998b) and impairment in
other protein-protein interactions such as neurotransmitter
release (Murray et al., 1997). Notably some of these molecular
consequences and functional deficits can be rescued by anti-
inflammatory agents such as IL-4, CD200, IL-10, minocycline
and eicosapentaenoic acid (EPA), which are inhibitors of
glial activation (Lynch, 1998b; Kelly et al., 2003; Lyons
et al., 2007a,b; Minogue et al., 2007; Clarke et al., 2008). It
is therefore likely that the imbalance between pro-inflammatory
and anti-inflammatory cytokines in the primed aged brain,
perhaps also attributed to by an imbalance in the periphery,
contributes significantly to age-related deficits in cognitive
function.
To support these changes observed in rodent models,
deficits in cognitive functions associated with inflammation have
been ostensibly reported in human patients receiving cytokine
treatment for cancer and hepatitis (Griffin et al., 2006; Ownby,
2010). Also, systemic influenza infections induced by active
systemic inflammatory substances that are capable of opening
the BBB specialization have been linked to neurobehavioral
dysfunction including cognitive deficits and also lethargy,
increased sleep/narcolepsy and social withdrawal (Ownby, 2010).
However, whether the neuroinflammatory effects of influenza are
a direct (i.e., primary) or indirect (i.e., secondary) causative factor
on cognitive dysfunction is yet to be determined at the preclinical
level.
Astrocytes are also known to be in close proximity to synaptic
structures. In the hippocampus it is thought that over 60% of
all axon-dendritic synapses are surrounded by finely branching
astroglial membrane processes, with peculiar specificity for large
perforated synapses (∼80%), which are presumably the most
functionally active, and <50% of smaller (macular) synapses
(Bushong et al., 2002; Ogata and Kosaka, 2002; Halassa et al.,
2007). A single protoplasmic astrocyte is estimated to contact
several hundred dendrites from multiple neurons and can
envelope 100,000 or more synapses (Sofroniew and Vinters,
2010). This intimate astroglial connection with synapses is thus
very important for support towards a host of synaptic functions
which include: (i) control of synaptogenesis, dendritic spine
cytoskeletal stabilization and remodeling (Murai et al., 2003);
(ii) ionic homeostasis; (iii) neuronal excitability; (iv) energy
support for neurons (Brown et al., 2004; Kofuji and Newman,
2004; Pellerin et al., 2007); (v) synthesis, uptake and recycling
of glutamate (Hertz and Zielke, 2004); and (vi) responding to
synaptic activity through bi-directional release of astrocytic-
secreted factors, synaptically active molecules or gliotransmitters
including glutamate, purines (ATP and adenosine), GABA,
lactate and D-serine and cell-cell interaction with contact-
mediated factors (Zhuo et al., 1993; Bezzi et al., 1998; Nishiyama
et al., 2002; Zhang et al., 2003). Because synaptic-astroglial
interactions are essential for healthy brain activity (Reichenbach
et al., 2010), modifications in this intimate structural relationship
may have a detrimental effect on the functional relationship
between astroglial cells and synapses in the aging brain;
most notably in glutamatergic circuits, which is particularly
important in hippocampal dependent learning and memory
processes.
In the hippocampus, astrocytes express glutamate receptors
(mGluR, NMDA and AMPA receptors) and can respond
to changes in neuronal glutamate levels (Sofroniew and
Vinters, 2010). It has been speculated that astrocytes are
able to synchronize with neuronal activity by sensing local
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changes in glutamate concentrations at glutamatergic synapses
through their receptors, resulting in the vesicular release
of gliotransmitters such as glutamate, ATP and D-serine
(a co-agonist of NMDA receptors) via exocytosis involving
calcium dependent mechanisms. These gliotransmitters bind
to their respective receptors to regulate influx of ions into
postsynaptic neurons and subsequent neuronal depolarization
that initiates the induction of LTP. This involves a cascade of
molecular mechanisms that stimulate the transient and persistent
activation of kinase enzymes, such as: calcium calmodullin
dependent protein kinase II (CaMKII), protein kinase A and
C (PKA, PKC) and mitogen activated protein kinase (MAPK)
that converges to initiate transcription factors (CORT1, CREB),
and the expression of synaptic plasticity during learning and
memory formation (Lynch, 1998a). Electron microscopy studies
have reported increased occurrence of perisynaptic astroglia
in tissue samples exposed to induction of LTP (Lushnikova
et al., 2009), whereas a memory consolidation task appeared
to decrease synaptic astroglial coverage (Ostroff et al., 2014).
We recently reported in a detailed morphometric study that
these astrocyte-synaptic interactions are significantly reduced
in the aged rat hippocampus (Ojo et al., 2012). We speculate
that during aging the astrocytic change from resting-quiescent
into a mild-to-moderate activated or hypertrophic state could
cause astrocytes to relinquish some of their neurosupportive
roles at the synapse. Possibly dampening down their ability to
sense incoming neuronal activity and reducing their production
and/or release of important gliotransmitters, thus resulting in an
impairment in the regulation of synaptic activity, information
processing at glutamatergic neural circuits and hence age-related
deficits in learning and memory processes.
In addition to directly releasing glutamate and related co-
agonists at glutamatergic synapses, astrocytes are also paramount
in regulating concentrations of glutamate levels at the synapse,
during neuronal activity. Uptake of synaptic glutamate is a major
mechanism that prevents accumulation in the synaptic space
and thus protects against excessive activation and excitotoxic
cell death (Fuller et al., 2009). Astrocytes express the glutamate
transporter EAAT2 or GLT1, which are a main regulator of
extracellular glutamate levels, and also contain enzyme glutamine
synthetase, which amidates glutamate to glutamine in an ATP-
dependent manner for recycling by neurons. Notably EAAT2
levels and gliosis were shown to inversely correlate in the aging
brain (Simpson et al., 2010), indicating that the hypertrophic
astrocytes in the aging brain may lose their expression of EAAT2,
with a resultant deficit in regulating glutamate levels during
synaptic activity.
Another important and often ignored gliotransmitter released
by astrocytes is lactate. During the process of memory formation,
which involves a cascade of cellular and molecular processes,
to ensure adequate functionality of neuronal activity, astrocytes
provide neurons with lactate, a useable and preferred energy
substrate. Lactate is produced by a process of glycogenolysis.
Astroglia end feet processes take up glucose transported across
the BBB via glucose transporter (GLUT) 1. Glucose is either
stored as glycogen or metabolized by glycolysis involving action
of lactate dehydrogenase (LDH) isoenzymes LDH5, resulting
in the production of lactate, which can be released into the
synapse through the mono-carboxylate transporters 1 and 4
(MCT1, MCT4; Ota et al., 2013). During synaptic activity
neurons take lactate via an MCT2 transporter and convert
this into pyruvate for oxidative metabolism (Ota et al., 2013).
This mechanism is supported by studies in rats showing that
inhibition of glycogenolysis and transporters MCT1, MCT4 or
MCT2 can induce memory impairment in inhibitory avoidance
and hippocampal dependent spatial memory tasks (Newman
et al., 2011; Suzuki et al., 2011). Because synaptic activity is
coupled to energy utilization through this astroglial-neuronal
interactive mechanism, involving metabolism of astrocytes, we
hypothesize that during aging this astrocyte-neuronal lactate
shuttle may also become significantly impaired due to a reduced
metabolic support of astrocytes in their hypertrophic state.
In addition to regulating synaptic activity through
gliotransmitters, astrocytes also have the potential to exert
powerful and long-term influences on synaptic function through
the release of growth factors and related molecules such as
nerve growth factor (NGF), basic fibroblast growth factor
(FGF), transforming growth factor-Beta (TGF-β), platelet-
derived growth factor (PDGF), brain-derived neurotrophic
factor (BDNF), cilliary neurotrophic factor (CNF), survival-
activity dependent neurotrophic factor (ADNF) and cytokine
TNF-α (Schwartz and Nishiyama, 1994; Rudge et al., 1995;
Dreyfus et al., 1999; Messersmith et al., 2000; Albrecht et al.,
2002).
LTP and memory consolidation have been shown to involve
the contributory roles of growth factors and cytokines, which are
highly expressed along with their receptors in the hippocampus
(Jankowsky and Patterson, 1999). These proteins can alter
neuronal morphology, gene expression and proliferation. The
best-studied growth factor is brain derived neurotrophic factor
(BDNF), highly concentrated in the hippocampus (Wetmore
et al., 1990; Murer et al., 2001). BDNF is largely produced
by astrocytes and is important in synaptic plasticity (and also
neurogenesis; see section Age-related neuroinflammation and
impact on hippocampal neurogenesis). It has been shown to
be an extremely potent modulator of theta burst induced LTP,
involving communication with the extracellular signal regulated
kinase (ERK) and p38 MAPK pathways and phosphorylation of
cAMP response element binding protein (CREB) transcription
factor, implicated in late phase LTP, gene transcription of
activity-regulated cytoskeleton-associated protein, Arc, protein
synthesis and spine-dendritic plasticity (Ying et al., 2002; Rex
et al., 2007). BDNF has been shown to decrease in late
adulthood in correlation with a decline in hippocampal volume
(Lommatzsch et al., 2005; Ziegenhorn et al., 2007; Erickson
et al., 2010). FGF, another growth factor largely produced by
hippocampal astrocytes located in the dentate gyrus has also been
largely studied, and its receptor FGFR1 has been demonstrated
to be required for LTP and memory consolidation, promoting
neurite outgrowth and enhancing synaptic connectivity (Zhao
et al., 2007). FGF-2 has been shown to also significantly decrease
with aging (Shetty et al., 2005).
Astroglial derived growth factor ADNF and cytokine TNF-
alpha have been demonstrated to influence homeostatic synaptic
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FIGURE 2 | Summary of age-related neuroglial response(s) in the brain
(hippocampus). The hippocampus is involved in the retrieval and consolidation
of memory, and with advanced aging hippocampal function progressively
deteriorates. These changes correlate with underlying hallmark neuroglial cell
response, typified by the activation of microglial and astroglial cells, robust
morphological changes, and an increase in phenotypic expression of antigen
activation markers (MHCII, CD68, CD45, GFAP). In addition, activated neuroglial
cells in aging also display increased production of pro-inflammatory cytokines
and their signaling profiles, phagocytic/lysosomal activity, toxic oxidative-lipid
products and a reduction in the production of anti-inflammatory cytokines and
neurotrophic factors. In microglial cells, these changes are thought to contribute
to their priming (and possible senescence), reducing their threshold of
tolerability and therefore shifting the balance to increased age-related
neuroinflammation and hence neurotoxicity. Astroglial cells, which are essential
in metabolic support of neurons and vascular cells, progressively relinquish
these supportive roles leading to deterioration in brain function. Together this
culminates in subtle impairments in dendritic integrity, synaptic function,
neurogenesis, increased oxidative metabolism, diminished protein clearance,
and microvascular deterioration. Abbreviation: (ROS) reactive oxygen species
such as nitric oxide, superoxide.
scaling by regulating glutamate release and insertion of AMPA
and NMDA receptors in the membrane of neighboring neuronal
synapses respectively (Blondel et al., 2000; Ota et al., 2013). These
mechanisms are essential for the maturation of synapses and the
maintenance of the post-synaptic density. Astroglial also produce
and release cholesterol, which is indispensable for synaptic
formation, providing building materials for new membranes,
also acting as precursors for conversion into neuroactive steroid
hormones that function as synaptogenic signals. Several other
astroglial factors including agrin and ephrin signaling have also
been implicated in regulating synaptic function, stimulating and
inhibiting synaptogenesis and dendritic outgrowth respectively
through actin rearrangement (Ota et al., 2013). We hypothesize
that the disruption of these pleiotropic neurosupportive roles
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of astrocytes mediated by the exhaustive lists of secreted
membrane bound or releasable astroglial factors with aging may
carry serious deleterious consequences on synaptic and other
physiological functions.
Neuron-Microglia Interactions and Glial
Inhibitory Factors in Aging
Neurons are now accepted as vital inflammatory/glial cell
modulators in the brain. They have been shown in different
experimental/clinical settings to control astrocyte and microglial
activity. Several neuronal signaling molecules including TREM2
and CD200, which have both received a wide variety of
attention in the past few years have been proposed to play
a prominent surveillance role in influencing the inflammatory
milieu of the CNS (Biber et al., 2007). TREM2 is an anti-
inflammatory ligand and danger associated molecular pattern
protein (DAMP) that controls CNS immune homeostasis by
interacting with its innate immune receptor TREM2R on
microglia cells. Specifically, TREM is released from apoptotic
neurons and controls microglial phagocytosis and clearance.
Mutations of TREM2 exhibit the pathological hallmarks of the
neurodegenerative disease Nasu Hakola or PLOSL (Takahashi
et al., 2005; Neumann and Takahashi, 2007). No studies
to date have established a link between aging and TREM2
dependent microglial function. It is possible that the underlying
accumulation of protein aggregates present in aged brains (Davis
et al., 1999) are by-products of an ineffective role of TREM2
dependent signaling in controlling microglia clearance of
potentially toxic cellular debris. Other cell surface factors such as
low-density lipoprotein receptor (LDL-R), LDL receptor related
protein-1 (LRP1), alpha-macroglobulin, scavenger receptor—A1
(SR-A1) and Formyl peptide receptor like receptor (FPRL)
implicated in microglia clearance mechanisms may also be
implicated.
Neuronal CD200 is a glycoprotein that interacts via cell-
cell contact with its cognate receptor (CD200R) localized
mainly on cells of the myeloid lineage including microglial
cells (Barclay et al., 2002). Activation of CD200R has been
shown to spatially modulate the extent of glial activation by
induction of quiescence (Lyons et al., 2007a). A number of
studies have provided substantial evidence that the absence
of CD200-CD200R interaction results in the damage and loss
of neurons, and hyper-responsiveness of glial cells leading to
a neurodegenerative pathology and functional impairment
(Popovich and Longbrake, 2008). CD200 knock out mice have
been shown to exhibit sporadic activation of glial cells (Broderick
et al., 2002) and antibody-mediated blocking of CD200 in in
vivo and in vitro models have demonstrated evidence of
neurodegeneration (Meuth et al., 2008). Blocking of CD200R in
vivo also augmented pathological/clinical signs of experimental
autoimmune encephalomyelitis (EAE) in rodents (Hoek et al.,
2000; Broderick et al., 2002). Consistent with these findings, a
deficit in LTP induced by LPS stimulation was rescued by intra-
cerebroventricular injections of CD200Fc immunoglobulins
(Lynch, 2010; Cox et al., 2012). These studies highlight the pivotal
role of CD200 in protecting against inflammatory reactions in
the normal healthy brain, where its levels are reportedly reduced
(Ojo et al., 2012; Cox et al., 2012). Low levels of CD200 (including
other glial inhibitory factors, such as, CX3CL1:CX3CR1) could
therefore contribute to the primed neuroinflammatory state of
glial cells frequently reported in aged brains.
Conclusion
The hippocampus is one of the brain regions that are vulnerable
to age-related deterioration. It is constantly engaged in the spatial
processing of episodic and declarative memory of information
throughout life. An underlying neuroinflammatory response in
the hippocampus, typified by astrocyte and microglial activation
and an increased pro-inflammatory cytokine production is
one of the major hallmarks of aging. This may occur without
concurrent incipient pathology. Neuroinflammatory cells in
this state could function abnormally losing their quiescent
mechanisms, becoming over-responsive to stress or/stimuli,
producing neurotoxic and proinflammatory molecules, and
surrendering pivotal metabolic and neurosupportive roles,
ultimately altering important physiological functions (see
summary Figure 2). A major challenge for future consideration
in this field is to determine what factors are involved in
maintaining neuroinflammatory cells in a quiescent non-
inflammatory state in the brain, and whether pharmacological
manipulations might be important in preserving hippocampal
and hence cognitive function in aged individuals.
Funding
Supported by the European Union FPVI ‘‘Promemoria’’
programme grant (Contract No. 512012), FP7 ‘‘MemStick’’ (Ref:
201600) and BBSRC grant BB/J021687/1.
References
Aine, C. J., Sanfratello, L., Adair, J. C., Knoefel, J. E., Caprihan, A., and Stephen,
J. M. (2011). Development and decline of memory functions in normal,
pathological and healthy successful aging. Brain Topogr. 24, 323–339. doi: 10.
1007/s10548-011-0178-x
Albrecht, P. J., Dahl, J. P., Stoltzfus, O. K., Levenson, R., and Levison, S. W.
(2002). Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating
their production and release of FGF-2, to increase motor neuron survival. Exp.
Neurol. 173, 46–62. doi: 10.1006/exnr.2001.7834
Altman, J., and Das, G. D. (1965). Autoradiographic and histological evidence of
postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 124, 319–335.
doi: 10.1002/cne.901240303
Amenta, F., Bronzetti, E., Sabbatini, M., and Vega, J. A. (1998). Astrocyte
changes in aging cerebral cortex and hippocampus: a quantitative
immunohistochemical study.Microsc. Res. Tech. 43, 29–33. doi: 10.
1002/(sici)1097-0029(19981001)43:1<29::aid-jemt5>3.0.co;2-h
Barclay, A. N., Wright, G. J., Brooke, G., and Brown, M. H. (2002).
CD200 and membrane protein interactions in the control of myeloid
cells. Trends Immunol. 23, 285–290. doi: 10.1016/s1471-4906(02)
02223-8
Frontiers in Aging Neuroscience | www.frontiersin.org 11 April 2015 | Volume 7 | Article 57
Ojo et al. Aging, neuroglial cells and hippocampal deterioration
Barry, C. E., Nolan, Y., Clarke, R. M., Lynch, A., and Lynch, M. A.
(2005). Activation of c-Jun-N-terminal kinase is critical in mediating
lipopolysaccharide-induced changes in the rat hippocampus. J. Neurochem. 93,
221–231. doi: 10.1111/j.1471-4159.2004.03011.x
Beattie, E. C., Stellwagen, D., Morishitta, W., Bresnahan, J. C., Ha, B. K., Von
Zastrow, M., et al. (2002). Control of synaptic strength by glial TNFα. Science
295, 2282–2285. doi: 10.1126/science.1067859
Berchtold, N. C., Cribbs, D. H., Coleman, P. D., Rogers, J., Head, E., Kim, R.,
et al. (2008). Gene expression changes in the course of normal brain aging
are sexually dimorphic. Proc. Natl. Acad. Sci. U S A 105, 15605–15610. doi: 10.
1073/pnas.0806883105
Bezzi, P., Carmignoto, G., Pasti, L., Vesce, S., Rossi, D., Rizzini, B. L., et al. (1998).
Prostaglandins stimulate calcium-dependent glutamatee release in astrocytes.
Nature 391, 281–285. doi: 10.1038/34651
Biber, K., Neumann, H., Inoue, K., and Boddeke, H.W. (2007). Neuronal ‘On’ and
‘Off’ signals controlmicroglia.Trends Neurosci. 30, 596–602. doi: 10.1016/j.tins.
2007.08.007
Bishop, N. A., Lu, T., and Yankner, B. A. (2010). Neural mechanisms of aging and
cognitive decline. Nature 464, 529–535. doi: 10.1038/nature08983
Bliss, T. V., and Collingridge, G. L. (1993). A synapticmodel ofmemory: long-term
potentiation in the hippocampus. Nature 361, 31–39. doi: 10.1038/361031a0
Block, M. L., and Hong, J. S. (2005). Microglia and inflammation-mediated
neurodegeneration: multiple triggers with a common mechanism. Prog.
Neurobiol. 76, 77–98. doi: 10.1016/j.pneurobio.2005.06.004
Blondel, O., Collin, C., McCarran, W. J., Zhu, S., Zamostiano, R., Gozes, I., et al.
(2000). A glia-derived signal regulating neuronal differentiation. J. Neurosci. 20,
8012–8020.
Braak, H. (1979). Spindle-shaped appendages of IIIab-pyramids filled with
lipofuscin: striking pathological change of the senescent human isocortex. Acta
Neuropathol. 46, 197–202. doi: 10.1007/bf00690844
Braak, H., and Braak, E. (1991). Neuropathological staging of Alzheimer-related
changes. Acta Neuropathol. 82, 239–259. doi: 10.1007/bf00308809
Breteler, M. M. (2000). Vascular involvement in cognitive decline and dementia.
Ann. N Y Acad. Sci. 903, 457–465. doi: 10.1111/j.1749-6632.2000.tb06399.x
Brevik, E. J., Eikeland, R. A., and Lundervold, A. J. (2013). Subthreshold depressive
symptoms have a negative impact on cognitive functioning in middle-aged and
older males. Front. Psychol. 4:309. doi: 10.3389/fpsyg.2013.00309
Broderick, C., Hoek, R. M., Forrester, J. V., Liversidge, J., Sedgwick, J. D., and
Dick, A. D. (2002). Constitutive retinal CD200 expression regulates resident
microglia and activation state of inflammatory cells during experimental
autoimmune uveoretinitis. Am. J. Pathol. 161, 1669–1677. doi: 10.1016/s0002-
9440(10)64444-6
Bronson, R. T., Lipman, R. D., and Harrison, D. E. (1993). Age-related gliosis
in the white matter of mice. Brain Res. 609, 124–128. doi: 10.1016/0006-
8993(93)90864-J
Brown, A. M., Baltan Tekkök, S., and Ransom, B. R. (2004). Energy transfer from
astrocytes to axons: the role of CNS glycogen. Neurochem. Int. 45, 529–536.
doi: 10.1016/j.neuint.2003.11.005
Buée, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., et al.
(1994). Pathological alterations of the cerebral microvasculature in Alzheimer’s
disease and related dementing disorders. Acta Neuropathol. 87, 469–480.
doi: 10.1007/bf00294173
Burger, C. (2010). Region-specific genetic alterations in the aging hippocampus:
implications for cognitive aging. Front. Aging Neurosci. 2:140. doi: 10.
3389/fnagi.2010.00140
Bushong, E. A., Martone, M. A., Jones, Y. Z., and Ellisman, M. H. (2002).
Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical
domains. J. Neurosci. 22, 183–192.
Butterfield, D. A., and Sultana, R. (2007). Redox proteomics identification of
oxidatively modified brain proteins in Alzheimer’s disease and mild cognitive
impairments: insights into the progression of this dementing disorder.
J. Alzheimers Dis. 12, 61–72.
Cameron, H. A., Woolley, C. S., McEwen, B. S., and Gould, E. (1993).
Differentiation of newly born neurons and glia in the dentate gyrus of the adult
rat. Neuroscience 56, 337–344. doi: 10.1016/0306-4522(93)90335-d
Carson, M. J., Bilousova, T. V., Puntambekar, S. S., Melchior, B., Doose, J. M., and
Ethell, I. M. (2007). A rose by any other name? The potential consequences of
microglial heterogeneity during CNS health and disease. Neurotherapeutics 4,
571–579. doi: 10.1016/j.nurt.2007.07.002
Clarke, R. M., Lyons, A., O’Connell, F., Deighan, B. F., Barry, C. E., Anyakoha,
N. G., et al. (2008). A pivotal role for interleukin-4 in atorvastatin-associated
neuroprotection in rat brain. J. Biol. Chem. 283, 1808–1817. doi: 10.1074/jbc.
m707442200
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., and Lukiw,
W. J. (2002). Gene expression profiling of 12633 genes in Alzheimer
hippocampal CA1: transcription and neurotrophic factor down-regulation and
up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70,
462–473. doi: 10.1002/jnr.10351
Conde, J. R., and Streit, W. J. (2006). Microglia in the aging brain. J. Neuropathol.
Exp. Neurol. 65, 199–203. doi: 10.1097/01.jnen.0000202887.22082.63
Cotrina, M. L., and Nedergaard, M. (2002). Astrocytes in the aging brain.
J. Neurosci. Res. 67, 1–10. doi: 10.1002/jnr.10121
Cox, F. F., Carney, D., Miller, A. M., and Lynch, M. A. (2012). CD200 fusion
protein decreases microglial activation in the hippocampus of aged rats. Brain
Behav. Immun. 26, 789–796. doi: 10.1016/j.bbi.2011.10.004
Craik, F. I. M., and Jennings, J. M. (1992). ‘‘Human memory,’’ in Handbook of
Aging and Cognition, eds F. I. M. Craik and T. A. Salthouse (Hillsdale, N.J.:
Lawrence Erlbaum Associates), 51–83.
Cribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner,
A. J., et al. (2012). Extensive innate immune gene activation accompanies brain
aging, increasing vulnerability to cognitive decline and neurodegeneration:
a microarray study. J. Neuroinflammation 9:179. doi: 10.1186/1742-
2094-9-179
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., and Perry,
V. H. (2005). Central and systemic endotoxin challenges exacerbate the
local inflammatory response and increase neuronal death during chronic
neurodegeneration. J. Neurosci. 25, 9275–9284. doi: 10.1523/jneurosci.2614-
05.2005
David, J. P., Ghozali, F., Fallet-Bianco, C., Wattez, A., Delaine, S., Boniface, B.,
et al. (1997). Glial reaction in the hippocampal formation is highly correlated
with aging in human brain. Neurosci. Lett. 235, 53–56. doi: 10.1016/s0304-
3940(97)00708-8
Davis, D. G., Schmitt, F. A., Wekstein, D. R., and Markesbery, W. R. (1999).
Alzheimer neuropathologic alterations in aged cognitively normal subjects.
J. Neuropathol. Exp. Neurol. 58, 376–388. doi: 10.1097/00005072-199904000-
00008
Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies,
P., et al. (1992). Identification of normal and pathological aging in prospectively
studied nondemented elderly humans. Neurobiol. Aging 13, 179–189. doi: 10.
1016/0197-4580(92)90027-u
Dilger, R. N., and Johnson, R. W. (2008). Aging, microglial cell priming
and the discordant central inflammatory response to signals from the
peripheral immune system. J. Leukoc. Biol. 84, 932–939. doi: 10.1189/jlb.02
08108
Dreyfus, C. F., Dai, X., Lercher, L. D., Racey, B. R., Friedman, W. J., and Black,
I. B. (1999). Expression of neurotrophins in the adult spinal cord in vivo.
J. Neurosci. Res. 56, 1–7. doi: 10.1002/(sici)1097-4547(19990401)56:1<1::aid-
jnr1>3.0.co;2-3
Ekdahl, C. T., Claasen, J. H., Bonde, S., Kokaia, Z., and Lindvall, O. (2003).
Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad.
Sci. U S A 100, 13632–13637. doi: 10.1073/pnas.2234031100
Erickson, K. I., Prakash, R. S., Voss, M. W., Chaddock, L., Heo, S., McLaren,
M., et al. (2010). Brain-derived neuroteophic factor is associated with age-
related decline in hippocampal volume. J. Neurosci. 30, 5368–5375. doi: 10.
1523/JNEUROSCI.6251-09.2010
Esiri, M. M. (2000). Which vascular lesions are of importance in vascular
dementia? Ann. N Y Acad. Sci. 903, 239–243. doi: 10.1111/j.1749-6632.2000.
tb06373.x
Esiri, M. M., Nagy, Z., Smith, M. Z., Barnetson, L., and Smith, A. D.
(1999). Cerebrovascular disease and threshold for dementia in the early
stages of Alzheimer’s disease. Lancet 354, 919–920. doi: 10.1016/s0140-6736
(99)02355-7
Flanary, B. E., Sammons, N. W., Nguyen, C., Walker, D., and Streit, W. J.
(2007). Evidence that aging and amyloid promote microglial cell senescence.
Rejuvenation Res. 10, 61–74. doi: 10.1089/rej.2006.9096
Flanary, B. E., and Streit, W. J. (2003). Telomeres shorten with age in rat
cerebellum and cortex in vivo. J. Anti. Aging Med. 6, 299–308. doi: 10.
1089/109454503323028894
Frontiers in Aging Neuroscience | www.frontiersin.org 12 April 2015 | Volume 7 | Article 57
Ojo et al. Aging, neuroglial cells and hippocampal deterioration
Frank, M. G., Barrientos, R. M., Watkins, L. R., and Maier, S. F. (2010).
Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo.
J. Neuoimmunol. 228, 181–184. doi: 10.1016/j.jneuroim.2010.05.022
Fuller, S., Münch, G., and Steele, M. (2009). Activated astrocytes: a therapeutic
target in Alzheimer’s disease? Expert Rev. Neurother. 9, 1585–1595. doi: 10.
1586/ern.09.111
Gallagher, M., and Rapp, P. R. (1997). The use of animal models to study the effects
of aging on cognition. Annu. Rev. Psychol. 48, 339–370. doi: 10.1146/annurev.
psych.48.1.339
Geinisman, Y., Bondareff, W., and Dodge, J. T. (1978). Hypertrophy of astroglial
processes in the dentate gyrus of the senescent rat. Am. J. Anat. 153, 537–543.
doi: 10.1002/aja.1001530405
Geinisman, Y., de Toledo-Morrell, L., and Morrell, F. (1986a). Aged rats need
a preserved complement of perforated axospinous synapses per hippocampal
neuron to maintain good spatial memory. Brain Res. 398, 266–275. doi: 10.
1016/0006-8993(86)91486-1
Geinisman, Y., de Toledo-Morrell, L., and Morrell, F. (1986b). Loss of perforated
synapses in the dentate gyrus: morphological substrate of memory deficit in
aged rats. Proc. Natl. Acad. Sci. U S A 83, 3027–3031. doi: 10.1073/pnas.83.9.
3027
Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W.,
et al. (2005). Exaggerated neuroinflammation and sickness behavior in aged
mice following activation of the peripheral innate immune system. FASEB J.
19, 1329–1331.
Golomb, J., de Leon, M. J., Kluger, A., George, A. E., Tarshish, C., and Ferris,
S. H. (1993). Hippocampal atrophy in normal aging: an association with recent
memory impairment. Arch. Neurol. 50, 967–973. doi: 10.1001/archneur.1993.
00540090066012
Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3,
23–35. doi: 10.1038/nri978
Goss, J. R., Finch, C. E., and Morgan, D. G. (1991). Age-related changes in glial
fibrillary acidic protein RNA in the mouse brain.Neurobiol. Aging 12, 165–170.
doi: 10.1016/0197-4580(91)90056-p
Grady, C. L., McIntosh, A. R., Horwitz, B., Maisog, J., Ungerleider, L., Mentis,
M. J., et al. (1995). Age-related reductions in human recognition memory due
to impaired encoding. Science 269, 218–221. doi: 10.1126/science.7618082
Griffin, R., Nally, R., Nolan, Y., McCartney, Y., Linden, J., Lynch, M. A., et al.
(2006). The age-related attenuation in long-term potentiation is associated with
microglial activation. J. Neurochem. 99, 1263–1272. doi: 10.1111/j.1471-4159.
2006.04165.x
Halassa, M. M., Fellin, T., Takamo, H., Dong, J. H., and Haydon, P. G. (2007).
Synaptic islands defined by the territory of a single astrocyte. J. Neurosci. 27,
6473–6477. doi: 10.1523/jneurosci.1419-07.2007
Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile
effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394.
doi: 10.1038/nn1997
Hayashi, Y., Yoshida, M., Yamato, M., Ide, T., Wu, Z., Ochi-Shindou,
M., et al. (2008). Reverse of age-dependent memory impairment and
mitochondrial DNA damage in microglia by an overexpression of human
mitochondrial transcription factor a inmice. J. Neurosci. 28, 8624–8634. doi: 10.
1523/JNEUROSCI.1957-08.2008
Henry, C. J., Huang, Y., Wynne, A. M., and Godbout, J. P. (2009). Peripheral
lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged
mice that is associated with exaggerated induction of both pro-inflammatory
IL-1 beta and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 23,
309–317. doi: 10.1016/j.bbi.2008.09.002
Hertz, L., and Zielke, H. R. (2004). Astrocytic control of glutamatergic activity:
astrocytes as stars of the show. Trends Neurosci. 27, 735–743. doi: 10.1016/j.
tins.2004.10.008
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R.,
Zurawski, S. M., et al. (2000). Down-regulation of the macrophage lineage
through interaction with OX2. CD(200). Science 290, 1768–1771. doi: 10.1126/
science.290.5497.1768
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., et al.
(2009). Systemic inflammation and disease progression in Alzheimer disease.
Neurology 73, 768–774. doi: 10.1212/WNL.0b013e3181b6bb95
Htain, W. W., Leong, S. K., and Ling, E. A. (1994). A comparative Mac-1
immunocytochemical and lectin histochemical study of microglia cells in
normal and athymic mice. Glia 12, 44–51. doi: 10.1002/glia.440120106
Hughes, C. C. W., and Lantos, P. L. (1987). A morphometric study of blood vessel,
neuron and glial cell distribution in young and adult rat brain. J. Neurosci. 79,
101–110. doi: 10.1016/0022-510x(87)90264-4
Jankowsky, J. L., and Patterson, P. H. (1999). Cytokine and growth factor
involvement in long-tem potentiation.Mol. Cell. Neurosci. 14, 273–286. doi: 10.
1006/mcne.1999.0792
Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I.,
Torres, M., Sanchez-Varo, R., et al. (2008). Inflammatory response in the
hippocampusof PS1M146L/APP751SL mouse model of Alzheimer’s disease:
age-dependentswitch in the microglial phenotype from alternative to classic.
J. Neurosci. 28, 11650–11661. doi: 10.1523/JNEUROSCI.3024-08.2008
Kelly, A., Vereker, E., Nolan, Y., Brady, M., Barry, C., Loscher, C. E., et al.
(2003). Activation of p38 plays a pivotal role in the inhibitory effect of
lipopolysaccharide and interleukin-1 beta on long term potentiation in
rat dentate gyrus. J. Biol. Chem. 278, 19453–19462. doi: 10.1074/jbc.m301
938200
Kennedy, D. W., and Abkowitz, J. L. (1997). Kinetics of central nervous system
microglial and macrophage engraftment: analysis using a transgenic bone
marrow transplantation model. Blood 90, 986–993.
Kimelberg, H. K. (2004). The problem of astrocyte identity. Neurochem. Int. 45,
191–202. doi: 10.1016/j.neuint.2003.08.015
Kimura, T., Takamatsu, J., Ikeda, K., Kondo, A., Miyakawa, T., and Horiuchi,
S. (1996). Accumulation of advanced glycation end products of the Maillard
reaction with age in human hippocampal neurons. Neurosci. Lett. 208, 53–56.
doi: 10.1016/0304-3940(96)12537-4
Kimura, T., Takamatsu, J., Miyata, T., Miyakawa, T., and Horiuchi, S.
(1998). Localization of identified advanced glycation end-product structures,
N(carboxymethyl)lysine and pentosidine, in age-related inclusions in
human brains. Pathol. Int. 48, 575–579. doi: 10.1111/j.1440-1827.1998.
tb03953.x
Kofuji, P., and Newman, E. A. (2004). Potassium buffering in the central nervous
system. Neuroscience 129, 1045–1056. doi: 10.1016/j.neuroscience.2004.06.008
Kohama, S. G., Goss, J. R., Finch, C. E., andMcNeill, T. H. (1995). Increases of glial
fibrillary acidic protein in the aging female mouse brain. Neurobiol. Aging 16,
59–67. doi: 10.1016/0197-4580(95)80008-f
Kuhn, H. G., Dickinson-Anson, H., and Gage, F. H. (1996). Neurogenesis in the
dentate gyrus of the adult rat: age-related decrease of neuronal progenitor
proliferation. J. Neurosci. 16, 2027–2033.
Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990). Heterogeneity in the
distribution and morphology of microglia in the normal adult mouse brain.
Neuroscience 39, 151–170. doi: 10.1016/0306-4522(90)90229-w
Lenze, E. J., Munin, M. C., Ferrell, R. E., Pollock, B. G., Skidmore, E., Lotrich, F.,
et al. (2005). Association of the serotonin transporter gene-linked polymorphic
region (5-HTTLPR) genotype with depression in elderly persons after hip
fracture. Am. J. Geriatr. Psychiatry 13, 428–432. doi: 10.1097/00019442-
200505000-00014
Lister, J. P., and Barnes, C. A. (2009). Neurobiological changes in the hippocampus
during normative aging. Arch. Neurol. 66, 829–833. doi: 10.1001/archneurol.
2009.125
Lommatzsch, M., Zingler, D., Schuhbaeck, K., Schloetcke, K., Zingler, C., Schuff-
Werner, P., et al. (2005). The impact of age, weight and gender on BDNF levels
in human platelets and plasma. Neurobiol. Aging 26, 115–123. doi: 10.1016/j.
neurobiolaging.2004.03.002
Long, J. M., Kalehua, A. N., Muth, N. J., Calhoun, M. E., Jucker, M., Hengemihle,
J. M., et al. (1998). Stereological analysis of astrocyte and microglia in
aging mouse hippocampus. Neurobiol. Aging 19, 497–503. doi: 10.1016/s0197-
4580(98)00088-8
Lopes, K. O., Sparks, D. L., and Streit, W. J. (2008). Microglial dystrophy
in the aged and Alzheimer’s disease brain is associated with ferritin
immunoreactivity. Glia 56, 1048–1060. doi: 10.1002/glia.20678
Love, S., Nicoll, J. A., Hughes, A., and Wilcock, G. K. (2003). APOE and
cerebral amyloid angiopathy in the elderly.Neuroreport 14, 1535–1536. doi: 10.
1097/00001756-200308060-00027
Lukiw, W. J. (2004). Gene expression profiling in fetal, aged and Alzheimer
hippocampus: a continuum of stress-related signaling. Neurochem. Res. 29,
1287–1297. doi: 10.1023/b:nere.0000023615.89699.63
Lushnikova, I., Skibo, G., Muller, D., and Nikonenko, I. (2009). Synaptic
potentiation induces increased glial coverage of excitatory synapses in CA1
hippocampus. Hippocampus 19, 753–762. doi: 10.1002/hipo.20551
Frontiers in Aging Neuroscience | www.frontiersin.org 13 April 2015 | Volume 7 | Article 57
Ojo et al. Aging, neuroglial cells and hippocampal deterioration
Lynch, M. A. (1998a). Analysis of the mechanisms underlying the age-related
impairment in long-term potentiation in the rat. Rev. Neurosci. 9, 169–201.
doi: 10.1515/revneuro.1998.9.3.169
Lynch, M. A. (1998b). Age-related impairment in long-term potentiation in
hippocampus: a role for the cytokine, interleukin-1 beta? Prog. Neurobiol. 56,
571–589. doi: 10.1016/s0301-0082(98)00054-9
Lynch, M. A. (2010). Age-related neuroinflammatory changes negatively impact
on neuronal function. Front. Aging Neurosci. 1:6. doi: 10.3389/neuro.24.006.
2009
Lynch, A. M., and Lynch, M. A. (2002). The age-related increase in IL-1 type I
receptor in rat hippocampus is coupled with an increase in caspase-3 activation.
Eur. J. Neurosci. 15, 1779–1788. doi: 10.1046/j.1460-9568.2002.02012.x
Lyons, A., Downer, E. J., Crotty, S., Nolan, Y. M., Mills, K. H., and Lynch, M. A.
(2007a). CD200 ligand receptor interaction modulates microglial activation
in vivo and in vitro: a role for IL-(4). J. Neurosci. 27, 8309–8313. doi: 10.
1523/jneurosci.1781-07.2007
Lyons, A., Griffin, J., Costelloe, C. E., Clarke, R. M., and Lynch, M. A. (2007b). IL-4
attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro.
J. Neurochem. 101, 771–781. doi: 10.1111/j.1471-4159.2006.04370.x
Lyons, A., McQuillan, K., Deighan, B. F., O’Reilly, J. A., Downer, E. J., Murphy,
A. C., et al. (2009). Decreased neuronal CD200 expression in IL-4-deficient
mice results in increased neuroinflammation in response to lipopolysaccharide.
Brain Behav. Immun. 23, 1020–1027. doi: 10.1016/j.bbi.2009.05.060
Maher, F. O., Nolan, Y., and Lynch, M. A. (2005). Downregulation of IL-4-
induced signalling in hippocampus contributes to deficits in LTP in the aged
rat. Neurobiol. Aging 26, 717–728. doi: 10.1016/j.neurobiolaging.2004.07.002
Mandybur, T. I., Ormsby, I., and Zelman, F. P. (1989). Cerebral aging: a
quantitative study of gliosis in old nude mice. Acta Neuropathol. 77, 507–513.
doi: 10.1007/bf00687252
Martin, A. J., Friston, K. J., Colebatch, J. G., and Frackowiak, R. S. (1991).
Decreases in regional cerebral blood flow with normal aging. J. Cereb. Blood
Flow Metab. 11, 684–689. doi: 10.1038/jcbfm.1991.121
Mattson, M. P., and Magnus, T. (2006). Aging and neuronal vulnerability. Nat.
Rev. Neurosci. 7, 278–294. doi: 10.1038/nrn1886
McGeer, P. L., Itagaki, S., Boyes, B. E., and McGeer, E. G. (1988). Reactive
microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and
Alzheimer’s disease brains. Neurology 38, 1285–1291. doi: 10.1212/wnl.38.8.
1285
Messersmith, D. J., Murtie, J. C., Le, T. Q., Frost, E. E., and Armstrong, R. C.
(2000). Fibroblast growth factor 2 (FGF-2) and FGF receptor expression in an
experimental demyelinating disease with extensive remyelination. J. Neurosci.
Res. 62, 241–256. doi: 10.1002/1097-4547(20001015)62:2<241::aid-jnr9>3.0.
co;2-d
Meuth, S. G., Simon, O. J., Grimm, A., Melzer, N., Herrmann, A. M., Spitzer, P.,
et al. (2008). CNS inflammation and neuronal degeneration is aggravated by
impaired CD200-CD200R-mediated macrophage silencing. J. Neuroimmunol.
194, 62–69. doi: 10.1016/j.jneuroim.2007.11.013
Minogue, A. M., Lynch, A. M., Loane, D. J., Herron, C. E., and Lynch, M. A.
(2007). Modulation of amyloid-beta-induced and age-associated changes in rat
hippocampus by eicosapentaenoic acid. J. Neurochem. 103, 914–926. doi: 10.
1111/j.1471-4159.2007.04848.x
Moore, M., Piazza, A., Nolan, Y., and Lynch, M. A. (2007). Treatment with
dexamethasone and vitamin D3 attenuates neuroinflammatory age-related
changes in rat hippocampus. Synapse 61, 851–861. doi: 10.1002/syn.20433
Morris, R., Anderson, E., Lynch, G., and Baudry, M. (1986). Selective
impairment of learning and blockade of long-term potentiation by an N-
methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774–776. doi: 10.
1038/319774a0
Mosser, D. M. (2003). The many faces of macrophage activation. J. Leukoc. Biol.
73, 209–212. doi: 10.1189/jlb.0602325
Mrak, R. E., Griffin, S. T., and Graham, D. I. (1997). Aging-associated changes
in the human brain. J. Neuropathol. Exp. Neurol. 56, 1269–1275. doi: 10.
1097/00005072-199712000-00001
Murai, K. K., Nguyen, L. N., Irie, F., Yamaguchi, Y., and Pasquale, E. B.
(2003). Control of hippocampal dendritic spine morphology through ephrin-
A3/EphA4 signaling. Nat. Neurosci. 6, 153–160. doi: 10.1038/nn994
Murer, M. G., Yan, Q., and Raisman-Vozari, R. (2001). Brain-derived
neurotrophic factor in the control human brain and in Alzheimer’s disease and
Parkinson’s. Prog. Neurobiol. 63, 71–124. doi: 10.1016/s0301-0082(00)00014-9
Muresanu, D. F., Popa-Wagner, A., Stan, A., Buga, A. M., and Popescu, B. O.
(2014). The vascular component of Alzheimer’s disease. Curr. Neurovasc. Res.
11, 168–176. doi: 10.2174/1567202611666140408105333
Murray, C. A., McGahon, B., McBennett, S., and Lynch, M. A. (1997). Interleukin-
1 beta inhibits glutamate release in hippocampus of young, but not aged, rats.
Neurobiol. Aging 18, 343–348. doi: 10.1016/s0197-4580(97)80317-x
Neumann, H., and Takahashi, K. (2007). Essential role of the microglial triggering
receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue
immune homeostasis. J. Neuroimmunol. 184, 92–99. doi: 10.1016/j.jneuroim.
2006.11.032
Newman, L. A., Korol, D. L., and Gold, P. E. (2011). Lactate produced by
glycogenolysis in astrocytes regulates memory processing. PLoS One 6:e28427.
doi: 10.1371/journal.pone.0028427
Nichols, N. R., Day, J. R., Laping, N. J., Johnson, S. A., and Finch, C. E. (1993).
GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14,
421–429. doi: 10.1016/0197-4580(93)90100-p
Nicholson, D. A., Yoshida, R., Berry, R. W., Gallagher, M., and Geinisman, Y.
(2004). Reduction in size of perforated postsynaptic densities in hippocampal
axospinous synapses and age-related spatial learning impairments. J. Neurosci.
24, 7648–7653. doi: 10.1523/jneurosci.1725-04.2004
Nishimura, A., Ueda, S., Takeuchi, Y., Sawada, T., and Kawata, M. (1995).
Age-related decrease of serotonergic fibres and S-100 beta immunoreactivity
in the rat dentate gyrus. Neuroreport 6, 1445–1448. doi: 10.1097/00001756-
199507100-00021
Nishiyama, H., Knopfel, T., Endo, S., and Itohara, S. (2002). Glial protein S100B
modulates long-term neuronal synaptic plasticity. Proc. Natl. Acad. Sci. U S A
99, 4037–4042. doi: 10.1073/pnas.052020999
Nolan, Y., Maher, F. O., Martin, D. S., Clarke, R. M., Brady, M. T., Bolton, A. E.,
et al. (2005). Role of interleukin-4 in regulation of age-related inflammatory
changes in the hippocampus. J. Biol. Chem. 280, 9354–9362. doi: 10.1074/jbc.
m412170200
Ogata, K., and Kosaka, T. (2002). Structural and quantitative analysis of astrocytes
in the mouse hippocampus. Neuroscience 113, 221–233. doi: 10.1016/s0306-
4522(02)00041-6
Ogura, K., Ogawa, M., and Yoshida, M. (1994). Effects of aging on microglia
in the normal rat brain: immunohistochemical observations. Neuroreport 5,
1224–1226. doi: 10.1097/00001756-199406020-00016
Ojo, B., Davies, H., Rezaie, P., Gabbott, P., Colyer, F., Kraev, I., et al. (2013).
Age-induced loss of mossy fibre synapses on CA3 thorns in the CA3 stratum
lucidum. Neurosci. J. 2013:839535. doi: 10.1155/2013/839535
Ojo, B., Rezaie, P., Gabbott, P. L., Cowely, T. R., Medvedev, N. I., Lynch, M. A.,
et al. (2011). A neural cell adhesion molecule-derived peptide, FGL, attenuates
glial cell activation in the aged hippocampus. Exp. Neurol. 232, 318–328. doi: 10.
1016/j.expneurol.2011.09.025
Ojo, B., Rezaie, P., Gabbott, P. L., Davies, H., Colyer, F., Cowley, T. R., et al.
(2012). Age-related changes in the hippocampus (loss of synaptophysin and
glial-synaptic interaction) are modified by systemic treatment with an NCAM-
derived peptide, FGL. Brain Behav. Immun. 26, 778–788. doi: 10.1016/j.bbi.
2011.09.013
Okamoto, Y., Tanaka, M., Kasahara, A., Hara, T., Gotoh, Y., Fujita, N., et al.
(2012). Age-related changes of serum soluble interleukin 9 receptor (sil-9ra) in
healthy subjects. Indian J. Clin. Biochem. 27, 400–404. doi: 10.1007/s12291-012-
0216-9
O’Keefe, G. M., Nguyen, V. T., and Benveniste, E. N. (2002). Regulation
and function of class II major histocompatibility complex, CD40 and
B7 expression in macrophages and microglia: implications in neurological
diseases. J. Neurovirol. 8, 496–512. doi: 10.1080/13550280290100941
Olariu, A., Cleaver, K. M., and Cameron, H. A. (2007). Decreased neurogenesis in
aged rats results from loss of gran- ule cell precursors without lengthen- ing of
the cell cycle. J. Comp. Neurol. 501, 659–667. doi: 10.1002/cne.21268
Ostroff, L. E., Manzur, M. K., Cain, C. K., and Ledoux, J. E. (2014).
Synapses lacking astrocyte appear in the amygdala during consolidation of
pavlovian threat conditioning. J. Comp. Neurol. 522, 2152–2163. doi: 10.1002/
cne.23523
Ota, Y., Zanetti, A. T., and Hallock, R. M. (2013). The role of astrocytes in
the regulation of synaptic plasticity and memory formation. Neural Plast.
2013:185463. doi: 10.1155/2013/185463
Ownby, R. L. (2010). Neuroinflammation and cognitive aging. Curr. Psychiatry
Rep. 12, 39–45. doi: 10.1007/s11920-009-0082-1
Frontiers in Aging Neuroscience | www.frontiersin.org 14 April 2015 | Volume 7 | Article 57
Ojo et al. Aging, neuroglial cells and hippocampal deterioration
Pellerin, L., Bouzier-Sore, A. K., Aubert, A., Serres, S., Merle, M., Costalat, R., et al.
(2007). Activity-dependent regulation of energy metabolism by astrocytes: an
update. Glia 55, 1251–1262. doi: 10.1002/glia.20528
Perry, V. H., Cunningham, C., and Holmes, C. (2007). Systemic infections
and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7,
161–167. doi: 10.1038/nri2015
Perry, V. H., Matyszak, M. K., and Fearn, S. (1993). Altered antigen expression of
microglia in the aged rodent CNS. Glia 7, 60–67. doi: 10.1002/glia.440070111
Peters, A., Palay, S. L., andWebster, H. D. (1991). The Fine Structure of the Nervous
System. Oxford UP: New York.
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik,
R. J., et al. (2009). Mild cognitiveimpairment: ten years later. Arch. Neurol. 66,
1447–1455. doi: 10.1001/archneurol.2009.266
Popa-Wagner, A., Buga, A. M., Tica, A. A., and Albu, C. V. (2014).
Perfusion deficits, inflammation and aging precipitate depressive behaviour.
Biogerotonology 15, 439–448. doi: 10.1007/s10522-014-9516-1
Popovich, P. G., and Longbrake, E. E. (2008). Can the immune system be harnessed
to repair the CNS?. Nat. Rev. Neurosci. 9, 481–493. doi: 10.1038/nrn2398
Püntener, U., Booth, S. G., Perry, V. H., and Teeling, J. L. (2012). Long-term
impact of systemic bacterial infection on the cerebral vasculature andmicroglia.
J. Neuroinflammation 9:146. doi: 10.1186/1742-2094-9-146
Ransohoff, R. M., and Cardona, A. E. (2010). The myeloid cells of the
central nervous system parenchyma. Nature 468, 253–262. doi: 10.1038/nature
09615
Rao, M. S., Hattiangady, B., Abdel-Rahman, A., Stanley, D. P., and Shetty, A. K.
(2005). Newly born cells in the aging dentate gyrus display normal migration,
survival and neuronal fate choice but endure retarded early matu- ration. Eur.
J. Neurosci. 21, 464–476. doi: 10.1111/j.1460-9568.2005.03853.x
Rapp, P. R., and Gallagher, M. (1996). Preserved neuron number in the
hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci.
U S A 93, 9926–9930. doi: 10.1073/pnas.93.18.9926
Rapp, P. R., Rosenberg, R. A., and Gallagher, M. (1987). An evaluation of spatial
information processing in aged rats. Behav. Neurosci. 101, 3–12. doi: 10.
1037//0735-7044.101.1.3
Reichenbach, A., Derouiche, A., and Kirchhoff, F. (2010). Morphology and
dynamics of perisynaptic glia. Brain Res. Rev. 63, 11–25. doi: 10.1016/j.
brainresrev.2010.02.003
Reimer, M. M., McQueen, J., Searcy, L., Scullion, G., Zonta, B., Desmazieres,
A., et al. (2011). Rapid disruption of axon-glial integrity in response to mild
cerebral hypoperfusion. J. Neurosci. 31, 18185–18194. doi: 10.1523/jneurosci.
4936-11.2011
Rex, C. S., Lin, C. Y., Kramár, E. A., Chen, L. Y., Gall, C. M., and Lynch, G.
(2007). Brain-derived neurotrophic factor promotes long-term potentiation
and cytoskeletal changes in adult hippocampus. J. Neurosci. 27, 3017–3029.
doi: 10.1523/jneurosci.4037-06.2007
Rezaie, P. (2007). ‘‘Microglia, from origins to differentiation, distribution and
dynamics within the mammalian central nervous system,’’ in Trends in Glial
Research–Basic and Applied, eds S. T. Dheen and E. A. Ling (India: Research
Signpost), 1–41.
Richardson, K., Stephan, B. C., Ince, P. G., Brayne, C., Matthews, F. E., and Esiri,
M. M. (2012). The neuropathology of vascular disease in the medical research
council cognitive function and aging study (MRC CFAS). Curr. Alzheimer Res.
9, 687–696. doi: 10.2174/156720512801322654
Rodríguez, J. J., and Verkhratsky, A. (2011). Neuroglial roots of neurodegenerative
diseases?.Mol. Neurobiol. 43, 87–96. doi: 10.1007/s12035-010-8157-x
Rodríguez, J. J., Yeh, C. Y., Terzieva, S., Olabarria, M., Kulijewicz-Nawrot,
M., and Verkhratsky, A. (2014). Complex and region-specific changes in
astroglial markers in the aging brain.Neurobiol. Aging 35, 15–23. doi: 10.1016/j.
neurobiolaging.2013.07.002
Rozovsky, I., Finch, C. E., and Morgan, T. E. (1998). Age-related activation of
microglia and astrocytes: in vitro studies show persistent phenotypes of aging,
increased proliferation and resistance to down-regulation.Neurobiol. Aging 19,
97–103. doi: 10.1016/s0197-4580(97)00169-3
Rudge, J. S., Pasnikowski, E. M., Holst, P., and Lindsay, R. M. (1995). Changes
in neurotrophic factor expression and receptor activation following exposure
of hippocampal neuron/astrocyte cocultures to kainic acid. J. Neurosci. 15,
6856–6867.
Saijo, K., and Glass, C. K. (2011). Microglial cell origin and phenotypes in health
and disease. Nat. Rev. Immunol. 11, 775–787. doi: 10.1038/nri3086
Schacter, D. L., Savage, C. R., Alpert, N. M., Rauch, S. L., and Albert, M. S. (1996).
The role of hippocampus and frontal cortex in age-related memory changes:
a PET study. Neuroreport 7, 1165–1169. doi: 10.1097/00001756-199604260-
00014
Scheibel, A. B. (1984). ‘‘Changes in brain capillary structure in aging and
dementia,’’ in Senile Dementia Outlook for the Future, eds J. Wertheimer and
M. Marois (New York: Alan R. Liss, Inc.), 137–149.
Schipper, H.M. (1996). Astrocytes, brain aging and neurodegeneration.Neurobiol.
Aging 17, 467–480.
Schwartz, J. P., and Nishiyama, N. (1994). Neurotrophic factor gene expression
in astrocytes during development and following injury. Brain Res. Bull. 35,
403–407. doi: 10.1016/0361-9230(94)90151-1
Seki, T., and Arai, Y. (1995). Age-related production of new granule cells in
the adult dentate gyrus. Neuroreport 6, 2479–2482. doi: 10.1097/00001756-
199512150-00010
Sheffield, L. G., and Berman, N. E. (1998). Microglial expression of MHC class II
increases in normal aging of nonhuman primates. Neurobiol. Aging 19, 47–55.
doi: 10.1016/s0197-4580(97)00168-1
Shetty, A. K., Hattiangady, B., and Shetty, G. A. (2005). Stem/progenitor cell
proliferation factors FGF-2, IGF-1 and VEGF exhibit early decline during the
course of aging in the hippocampus: role of astrocytes.Glia 51, 173–186. doi: 10.
1002/glia.20187
Shors, T. J., Miesegaes, G., Beylin, A., Zhao, M., Rydel, T., and Gould, E. (2001).
Neurogenesis in the adult is involved in the formation of trace memories.
Nature 410, 372–376. doi: 10.1038/35066584
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., et al.
(2010). Astrocyte phenotype in relation to Alzheimer type pathology in the
ageing brain.Neurobiol. Aging 31, 578–590. doi: 10.1016/j.neurobiolaging.2008.
05.015
Simpson, J. E., Ince, P. G., Shaw, P. J., Heath, P. R., Raman, R., Garwood,
C. J., et al. (2011). MRC cognitive function and aging neuropathology study
group Microarray analysis of the astrocyte transcriptome in the aging brain:
relationship to Alzheimer’s pathology and APOE genotype. Neurobiol. Aging
32, 1795–1807. doi: 10.1016/j.neurobiolaging.2011.04.013
Small, S. A., Chawla, M. K., Buonocore, M., Rapp, P. R., and Barnes, C. A.
(2004). Imaging correlates of brain function in monkeys and rats isolates a
hippocampal subregion differentially vulnerable to aging. Proc. Natl. Acad. Sci.
U S A 101, 7181–7186. doi: 10.1073/pnas.0400285101
Sofroniew, M. V., and Vinters, H. V. (2010). Astrocytes: biology and pathology.
Acta Neuropathol. 119, 7–35. doi: 10.1007/s00401-009-0619-8
Streit, W. J. (2002). Microglia as neuroprotective, immunocompetent cells of the
CNS. Glia 40, 133–139. doi: 10.1002/glia.10154
Streit, W. J. (2006). Microglial senescence: does the brain’s immune system have
an expiration date?. Trends Neurosci. 29, 506–510. doi: 10.1016/j.tins.2006.
07.001
Streit,W. J., Braak, H., Xue, Q. S., and Bechmann, I. (2009). Dystrophic (senescent)
rather than activated microglial cells are associated with tau pathology and
likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol.
118, 475–485. doi: 10.1007/s00401-009-0556-6
Streit, W. J., Mrak, R. E., and Griffin, W. S. (2004). Microglia and
neuroinflammation: a pathological perspective. J. Neuroinflammation 1:14.
doi: 10.1186/1742-2094-1-14
Suzuki, A., Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H., Magistretti,
P. J., et al. (2011). Astrocyte-neuron lactate transport is required for
long-term memory formation. Cell 144, 810–823. doi: 10.1016/j.cell.2011.
02.018
Takahashi, K., Rochford, C. D., and Neumann, H. (2005). Clearance of
apoptotic neurons without inflammation by microglial triggering receptor
expressed on myeloid cells-2. J. Exp. Med. 201, 647–657. doi: 10.1084/jem.
20041611
Town, T., Nikolic, V., and Tan, J. (2005). The microglial ‘‘activation’’ continuum:
from innate to adaptive responses. J. Neuroinflammation 2:24. doi: 10.
1186/1742-2094-2-24
Trapp, B. D., Wujek, J. R., Criste, G. A., Jalabi, W., Yin, X., Kidd, G. J., et al. (2007).
Evidence for synaptic stripping by cortical microglia. Glia 55, 360–368. doi: 10.
1002/glia.20462
Tremblay,M. È., Lowery, R. L., andMajewska, A. K. (2010).Microglial interactions
with synapses are modulated by visual experience. PLoS Biol. 8:e1000527.
doi: 10.1371/journal.pbio.1000527
Frontiers in Aging Neuroscience | www.frontiersin.org 15 April 2015 | Volume 7 | Article 57
Ojo et al. Aging, neuroglial cells and hippocampal deterioration
Vallières, L., and Sawchenko, P. E. (2003). Bone marrow-derived cells that
populate the adult mouse brain preserve their hematopoietic identity.
J. Neurosci. 23, 5197–5207.
Varin, A., and Gordon, S. (2009). Alternative activation of macrophages: immune
function and cellular biology. Immunobiology 214, 630–641. doi: 10.1016/j.
imbio.2008.11.009
Varnum, M. M., and Ikezu, T. (2012). The classification of microglial activation
phenotypes on neurodegeneration and regeneration in Alzheimer’s disease
brain. Arch. Immunol. Ther. Exp. (Warsz) 60, 251–266. doi: 10.1007/s00005-
012-0181-2
Vasilevko, V., Passos, G. F., Quiring, D., Head, E., Kim, R. C., Fisher, M., et al.
(2010). Aging and cerebrovascular dysfunction: contribution of hypertension,
cerebral amyloid angiopathy and immunotherapy. Ann. N Y Acad. Sci. 1207,
58–70. doi: 10.1111/j.1749-6632.2010.05786.x
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Preboske, G. M.,
Kantarci, K., et al. (2015). Vascular and amyloid pathologies are independent
predictors of cognititve decline in normal eldely. Brain 138, 761–771. doi: 10.
1093/brain/awu393
von Bernhardi, R. J., Tichauer, J. E., and Eugenín, J. (2010). Aging-dependent
changes of microglial cells and their relevance for neurodegenerative
disorders. J. Neurochem. 112, 1099–1114. doi: 10.1111/j.1471-4159.2009.
06537.x
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., and Nabekura, J. (2009).
Resting microglia directly monitor the functional state of synapses in vivo and
determine the fate of ischemic terminals. J. Neurosci. 29, 3974–3980. doi: 10.
1523/jneurosci.4363-08.2009
Weller, R. O., Yow, H. Y., Preston, S. D., Mazanti, I., and Nicoll, J. A. (2002).
Cerebrovascular disease is a major factor in the failure of limination of
Abeta from the aging human brain: implications for therapy of Alzheimer’s
disease. Ann. N Y Acad. Sci. 977, 162–168. doi: 10.1111/j.1749-6632.2002.
tb04812.x
Wetmore, C., Ernfors, P., Persson, H., and Olson, L. (1990). Localization of
brain-derived neurotrophic factor mRNA to neurons in the brain by in situ
hybridization. Exp. Neurol. 109, 141–152. doi: 10.1016/0014-4886(90)90068-4
Wu, Y., Zhang, A. Q., and Yew, D. T. (2005). Age related changes of
various markers of astrocytes in senescence-accelerated mice hippocampus.
Neurochem. Int. 46, 565–574. doi: 10.1016/j.neuint.2005.01.002
Ye, S. M., and Johnson, R.W. (2001). An age-related decline in interleukin-10 may
contribute to the increased expression of interleukin-6 in brain of aged mice.
Neuroimmunomodulation 9, 183–192. doi: 10.1159/000049025
Ying, S. W., Futter, M., Rosenblum, K., Webber, M. J., Hunt, S. P., Bliss, T. V. P.,
et al. (2002). Brain-derived neurotrophic factor induces long term potentiation
in intact adult hippocampus: requirement for ERK activation coupled to CREB
and upregulation of Arc synthesis. J. Neurosci. 22, 1532–1540.
Zhang, J. M., Wang, H. K., Ye, C. Q., Ge, W., Chen, Y., Jiang, Z. L., et al.
(2003). ATP released by astrocytes mediates glutamatergic activity-dependent
heterosynaptic suppression. Neuron 40, 971–982. doi: 10.1016/s0896-
6273(03)00717-7
Zhao, M., Li, D., Shimazu, K., Zhou, Y. X., Lu, B., and Deng, C. X. (2007).
Fibroblast growth factor receptor-1 is required for long-term potentiation,
memory consolidation and neurogenesis. Biol. Psychiatry 62, 381–390. doi: 10.
1016/j.biopsych.2006.10.019
Zhuo, M., Small, S. A., Kandel, E. R., and Hawkins, R. D. (1993). Nitric
oxide and carbon monoxide produce activity-dependent long-term synaptic
enhancement in hippocampus. Science 260, 1946–1950. doi: 10.1126/science.
8100368
Ziegenhorn, A. A., Schulte-Herbrüggen, O., Danker-Hopfe, H., Malbranc, M.,
Hartung, H. D., Anders, D., et al. (2007). Serum neurotrophins—a study on
the time course and influencing factors in a large old age sample. Neurobiol.
Aging 28, 1436–1445. doi: 10.1016/j.neurobiolaging.2006.06.011
Zyzak, D. R., Otto, T., Eichenbaum, H. M., and Gallagher, M. (1995). Cognitive
decline associated normal aging in rats: a neuropsychological approach. Learn.
Mem. 2, 1–16. doi: 10.1101/lm.2.1.1
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Ojo, Rezaie, Gabbott and Stewart. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution and reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 16 April 2015 | Volume 7 | Article 57
